approval · primary record
SELINEXOR
FDA · NDA · 2026-04-23
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-04-23 |
| Brand | XPOVIO |
| Sponsor | KARYOPHARM THERAPS |
| Route | ORAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:29:28.401Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:SELINEXOR:2026-04-23
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.